Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03178773 · ClinicalTrials.gov registry record · Phase 2
TExT-MED + FANS Full Trial
A Phase 2 study of Diabetes, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 2
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT03178773: Completed Phase 2 study of Diabetes, sponsored by University of Southern California.
NCT03178773 is a Phase 2 study of Diabetes that has completed, run by University of Southern California. The registered enrollment target is 166 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03178773, a Phase 2 study of Diabetes, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an intervention to study incorporating social support into mHealth interventions for low-income, ED patients with diabetes
Primary Outcome
Glycemic control is measured by hemoglobin A1C collected at point-of-care from an Afinion AS100 capillary point of care machine. The Afinion machine has excellent point of care correlation with laboratory values. As a surrogate for average glycemic control over the previous 3 months and with correlation with clinical outcomes, hemoglobin A1c is a marker of overall clinical disease management. Change is baseline value minus follow up value.
Conditions Studied
Interventions
- BEHAVIORAL TExT-MED
- BEHAVIORAL FANS
Study Locations (1)
California
- LAC+USC Medicine Center Emergency Department - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2017-07-18 |
| Est. Completion | 2019-12-02 |
| Phase | Phase 2 |
What the finished NCT03178773 record still lists
NCT03178773 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which TExT-MED is the first listed.
NCT03178773 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03178773 about?
NCT03178773 is a clinical study titled "TExT-MED + FANS Full Trial". This is an intervention to study incorporating social support into mHealth interventions for low-income, ED patients with diabetes
What is the current status of trial NCT03178773?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 166 participants. The study started on 2017-07-18. Estimated completion is 2019-12-02.
What conditions does trial NCT03178773 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT03178773?
The interventions under investigation include: TExT-MED (BEHAVIORAL), FANS (BEHAVIORAL).
Who is sponsoring clinical trial NCT03178773?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03178773 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03178773's enrollment target sits among peer trials
166 159th of 338 higher than 180 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
RECRUITING · Phase 2
-
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
ACTIVE NOT RECRUITING · Phase 2
-
Biomarker Guided Therapies in Stage A/B Heart Failure
COMPLETED · Phase 2
-
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial
COMPLETED · Phase 2
-
Effects of Human Leptin Replacement
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI